- Home
- AVNS vs LXRX Comparison
AVNS vs LXRX Comparison
Compare AVNS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- LXRX
- Stock Information
- Founded
- AVNS 2014
- LXRX 1995
- Country
- AVNS United States
- LXRX United States
- Employees
- AVNS N/A
- LXRX N/A
- Industry
- AVNS Industrial Specialties
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AVNS Health Care
- LXRX Health Care
- Exchange
- AVNS Nasdaq
- LXRX Nasdaq
- Market Cap
- AVNS 521.7M
- LXRX 541.5M
- IPO Year
- AVNS N/A
- LXRX 2000
- Fundamental
- Price
- AVNS $11.24
- LXRX $1.46
- Analyst Decision
- AVNS
- LXRX Buy
- Analyst Count
- AVNS 0
- LXRX 5
- Target Price
- AVNS N/A
- LXRX $3.23
- AVG Volume (30 Days)
- AVNS 509.9K
- LXRX 2.2M
- Earning Date
- AVNS 11-05-2025
- LXRX 11-06-2025
- Dividend Yield
- AVNS N/A
- LXRX N/A
- EPS Growth
- AVNS N/A
- LXRX N/A
- EPS
- AVNS N/A
- LXRX N/A
- Revenue
- AVNS $699,900,000.00
- LXRX $70,864,000.00
- Revenue This Year
- AVNS $0.25
- LXRX $66.55
- Revenue Next Year
- AVNS $1.33
- LXRX N/A
- P/E Ratio
- AVNS N/A
- LXRX N/A
- Revenue Growth
- AVNS 2.70
- LXRX 1255.21
- 52 Week Low
- AVNS $9.30
- LXRX $0.28
- 52 Week High
- AVNS $19.91
- LXRX $1.66
- Technical
- Relative Strength Index (RSI)
- AVNS 46.72
- LXRX 52.71
- Support Level
- AVNS $10.92
- LXRX $1.36
- Resistance Level
- AVNS $12.00
- LXRX $1.64
- Average True Range (ATR)
- AVNS 0.52
- LXRX 0.12
- MACD
- AVNS -0.00
- LXRX 0.00
- Stochastic Oscillator
- AVNS 29.95
- LXRX 59.78
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.